Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0026
+0.0015 (136.36%)
At close: Dec 5, 2025
Affymax Market Cap
Affymax has a market cap or net worth of $193.67 thousand as of December 8, 2025. Its market cap has decreased by -58.06% in one year.
Market Cap
193.67K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.03
Stock Price
$0.00
Market Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 193.67K, a decrease of -99.96%. That is a compound annual growth rate of -33.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 193.67K | 225.00% |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | 7.45M | 300.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.88M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |